Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 4312-4317, August 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohler, J. L.
Right arrow Articles by Coffey, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohler, J. L.
Right arrow Articles by Coffey, D. S.

Metastatic Potential Prediction by a Visual Grading System of Cell Motility: Prospective Validation in the Dunning R-3327 Prostatic Adenocarcinoma Model1

James L. Mohler2, Alan W. Partin3, John T. Isaacs and Donald S. Coffey

Department of Urology, The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center, Baltimore, Maryland 21205

A method for accurate prediction of prognosis in individual patients with prostatic carcinoma does not exist. The limitations of pathological grading systems may result from the failure of standard pathological examination of fixed dead tissue to accurately assess the biological and metastatic behavior of live tumor cells. Many of the sublines of the Dunning R-3327 rat prostatic adenocarcinoma are histologically similar yet differ in metastatic potential. Cells from the Dunning model were grown in culture and filmed by time-lapse videomicroscopy. These cells exhibited characteristic membrane ruffling, pseudopodal extension, and cellular translation that could be graded with 80% reproducibility. Individual cells from sublines with high metastatic potential were separated from cells from sublines of low metastatic potential in 96% of cases. We have applied our cell motility grading system to prospectively classify the metastatic potential of neoplastic cells. The mean motility grades of sublines of high and low metastatic potential differed significantly (Mann-Whitney-Wilcoxon, P < 0.0005). Among seven sublines in which the grading system was developed, individual cells were correctly classified as high or low metastatic in 71% of cases by ruffling or pseudopodal extension, 73% of cases by translation, and 75% of cases by motility index, an average of the three parameters of motility. Among four newly tested sublines, cells from a low metastatic and high metastatic subline were perfectly classified. Cells from two other low metastatic sublines were misclassified. When all 88 cells from the 11 sublines were classified, high metastatic cells were detected with 94% sensitivity and 50% specificity. The predictive value of a determination of low metastatic was 93%, whereas the predictive value of an assignment of high metastatic was 52%. The ability to detect and accurately classify most highly metastatic cells while rarely erring in a classification of low metastatic potential suggests that a grading system of cancer cell motility should be evaluated in human prostatic carcinoma. The motility of live prostatic carcinoma cells may predict patient prognosis better than standard pathological grading systems.

1 This work was supported by Grant CA 15416 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at University of North Carolina at Chapel Hill, Division of Urology, Burnett-Womack Clinical Sciences Building CB#7050, Chapel Hill, NC 27599-7050.

3 Supported by the Medical Scientist Training Program, Training Grant 5T32 GM07309.

Received 7/15/87. Revised 2/29/88. Accepted 5/ 4/88.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Hanzawa, M. Shindoh, F. Higashino, M. Yasuda, N. Inoue, K. Hida, M. Ono, T. Kohgo, M. Nakamura, K.-i. Notani, et al.
Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes
Carcinogenesis, June 1, 2000; 21(6): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. Rinker-Schaeffer, M. Chekmareva, and J. Mohler
The role of motility proteins and metastasis-suppressor genes in prostate cancer progression
Stem Cells, September 1, 1996; 14(5): 508 - 516.
[Abstract]


Home page
Reproductive SciencesHome page
R. Goshen, H. Schreck, D. Komitowski, S. Karnaoukhova, B. Gonik, D. Weinstein, N. de Groot, and A. Hochberg
Morphologic Characteristics of the Interaction Between Normal Cytotrophoblasts and Their Malignant Counterpart in the Development of Trophoblastic Neoplasia
Reproductive Sciences, July 1, 1996; 3(4): 209 - 215.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.